This research study is about worldwide drug discovery R&D. The report discusses the current status of new drug products that are in the clinical trials pipeline and analyzes the data from several points of view. The comprehensive report provides readers with data gathered in a mid-2004 survey to identify, count, measure and analyze key developments driving R&D in the drug industry.
The worldwide drug making industry is both complex and challenging for all business participants. The study reviews key areas of the top 55 global pharma and biotech companys drug R&D activities and highlights their strategies and individual drug R&D clinical pipelines.
This must-have report takes the point of view of major disease categories and discusses key health issues identified through worldwide disease demographic data. The study divides ten major disease categories identifies 259 disease indications that drug makers are addressing with new drugs.
This research report analyzes the major disease categories of the drugs in 873 clinical trials that the drug companies are developing and ranks the most promising areas likely to yield high potential drug products. The report identifies potential blockbusters and maps them by potential market value and likely launch year through 2009.
The report discusses these important items with interesting and useful findings. This study uses more than 53 tables and charts to illustrate the findings. Detailed information about the activities of the top companies important to this market is listed in numerous areas of this report.
